Ушбу ишга иқтибос қилган ишлар

3 та иш

Иш: Intratumoral Delivery of Chimeric Antigen Receptor T Cells Targeting CD133 Effectively Treats Brain Metastases

1. Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?

   Manh-Cuong Vo, Van-Dinh-Huan Tran, Van‐Tan Nguyen +5

   МақолаCAR-T cell therapy researchJournal of Hematology & Oncology20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.000083

2. Engineering CAR T NK and NKT cell therapies to target cancer stem cells and overcome stem like resistance

   Omer Qutaiba B. Allela, Abdulkareem Shareef, S. Renuka Jyothi +9

   МақолаCAR-T cell therapy researchDiscover Oncology20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.001466

3. CAR-engineered neutrophils derived from induced pluripotent stem cells: a new frontier in cellular immunotherapy

   E. A Nemilostiva, O. A Paevskaya, Shuxrat Boymuradov +2

   МақолаPluripotent Stem Cells ResearchClinical & Translational Oncology20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.018185